Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia

被引：3
作者：
Millot, F
Brizard, F
Sorel, N
Preudhomme, C
Cividin, M
Guilhot, F
Brizard, A
机构：
[1] CHU Poitiers, Serv Oncol Hematol & Therap Cellulaire, F-86000 Poitiers, France
[2] Univ Hosp Lille, Hematol Lab, Lille, France
[3] Univ Hosp Poitiers, Hematol Lab, Poitiers, France
来源：
LEUKEMIA & LYMPHOMA | 2005年 / 46卷 / 06期
关键词：
DNA topoisomerase II inhibitors; therapy-related leukemia; Burkitt's leukemia; children;
D O I：
10.1080/10428190500052248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The occurrence of therapy-related acute lymphoblastic leukemia ( ALL) is rare and, to our knowledge, is not reported in patients treated for Burkitt's leukemia. We report on a child with ALL with translocation t( 4; 11)( q21; q23) involving the MLL gene, 13 months after chemotherapy for Burkitt's leukemia. This present observation indicates that caution should be exercised in using high cumulative doses of DNA topoisomerase II inhibitors in such patients.
引用
收藏
页码：925 / 927
页数：3
相关论文
共 15 条
[1]   Acute lymphoblastic leukemia with multiple cytogenetic abnormalities secondary to treatment of Ewing's sarcoma [J].
Al-Homaidhi, AM ;
Patterson, B ;
Rubin, S ;
Lipton, JH .
LEUKEMIA RESEARCH, 1999, 23 (06) :593-596
[2]   Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem:: report on two new cases and review of the literature since 1992 [J].
Andersen, MK ;
Christiansen, DH ;
Jensen, BA ;
Ernst, P ;
Hauge, G ;
Pedersen-Bjergaard, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :539-543
[3]   SECONDARY ACUTE LYMPHOBLASTIC-LEUKEMIA WITH T (4-11) - REPORT ON 2 CASES AND REVIEW OF THE LITERATURE [J].
AUXENFANTS, E ;
MOREL, P ;
LAI, JL ;
SARTIAUX, C ;
DETOURMIGNIES, L ;
BAUTERS, F ;
FENAUX, P .
ANNALS OF HEMATOLOGY, 1992, 65 (03) :143-146
[4]   Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites [J].
Broeker, PLS ;
Super, HG ;
Thirman, MJ ;
Pomykala, H ;
Yonebayashi, Y ;
Tanabe, S ;
ZeleznikLe, N ;
Rowley, JD .
BLOOD, 1996, 87 (05) :1912-1922
[5]   Secondary acute lymphoblastic leukemia in a child three years after treatment for medulloblastoma [J].
Casteels, K ;
Renard, M ;
Van Gool, S ;
Uyttebroeck, A .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (03) :390-391
[6]   Pitfalls in the diagnosis of childhood leukaemia [J].
Chessells, JM .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :506-511
[7]   Leukemias related to treatment with DNA topoisomerase II inhibitors [J].
Felix, CA .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (05) :525-535
[8]   Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique [J].
Le Deley, MC ;
Leblanc, T ;
Shamsaldin, A ;
Raquin, MA ;
Lacour, B ;
Sommelet, D ;
Chompret, A ;
Cayuela, JM ;
Bayle, C ;
Bernheim, A ;
de Vathaire, F ;
Vassal, G ;
Hill, C .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1074-1081
[9]  
LENNARD A, 1991, LEUKEMIA, V5, P624
[10]   Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents [J].
Nasr, F ;
MacIntyre, E ;
Venuat, AM ;
Bayle, C ;
Carde, P ;
Ribrag, V .
LEUKEMIA & LYMPHOMA, 1997, 25 (3-4) :399-401
12